MACCALLINI, Cristina
 Distribuzione geografica
Continente #
NA - Nord America 6.854
EU - Europa 4.205
AS - Asia 3.811
Continente sconosciuto - Info sul continente non disponibili 623
SA - Sud America 403
AF - Africa 61
OC - Oceania 4
Totale 15.961
Nazione #
US - Stati Uniti d'America 6.585
SG - Singapore 1.435
IT - Italia 1.050
CN - Cina 1.048
IE - Irlanda 488
TR - Turchia 444
UA - Ucraina 428
SE - Svezia 424
RU - Federazione Russa 384
VN - Vietnam 333
GB - Regno Unito 330
BR - Brasile 324
FR - Francia 313
IN - India 267
DE - Germania 234
CA - Canada 151
PL - Polonia 150
FI - Finlandia 120
AT - Austria 69
BD - Bangladesh 55
ES - Italia 50
HK - Hong Kong 50
LT - Lituania 45
MX - Messico 32
JP - Giappone 31
CZ - Repubblica Ceca 25
NL - Olanda 25
BE - Belgio 22
ZA - Sudafrica 20
AR - Argentina 18
ID - Indonesia 18
CR - Costa Rica 16
PK - Pakistan 16
VE - Venezuela 15
JM - Giamaica 14
KR - Corea 14
CO - Colombia 13
EC - Ecuador 12
IQ - Iraq 12
PH - Filippine 11
GT - Guatemala 10
AE - Emirati Arabi Uniti 9
CL - Cile 9
MY - Malesia 9
SA - Arabia Saudita 8
TT - Trinidad e Tobago 8
HN - Honduras 7
KE - Kenya 7
MA - Marocco 7
PT - Portogallo 7
SV - El Salvador 7
TW - Taiwan 7
IL - Israele 6
PR - Porto Rico 6
AL - Albania 5
CH - Svizzera 5
EE - Estonia 5
GR - Grecia 5
NI - Nicaragua 5
UZ - Uzbekistan 5
AU - Australia 4
CW - ???statistics.table.value.countryCode.CW??? 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
EG - Egitto 4
ET - Etiopia 4
HR - Croazia 4
IR - Iran 4
JO - Giordania 4
NP - Nepal 4
PE - Perù 4
PY - Paraguay 4
TN - Tunisia 4
BB - Barbados 3
BG - Bulgaria 3
DK - Danimarca 3
LB - Libano 3
SC - Seychelles 3
SK - Slovacchia (Repubblica Slovacca) 3
YE - Yemen 3
AZ - Azerbaigian 2
BH - Bahrain 2
KZ - Kazakistan 2
RO - Romania 2
RS - Serbia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BM - Bermuda 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
Totale 15.329
Città #
Singapore 1.080
San Jose 768
Chandler 605
Ashburn 515
Jacksonville 512
Dublin 477
Izmir 282
Beijing 268
Dallas 234
Dearborn 233
Chieti 213
Southend 198
Princeton 194
Council Bluffs 181
Santa Clara 155
Nanjing 150
Los Angeles 143
The Dalles 136
Ann Arbor 120
Ho Chi Minh City 113
Kraków 108
Cambridge 103
Wilmington 96
New York 89
Hanoi 70
Nanchang 66
Pescara 66
Buffalo 64
Washington 64
Altamura 62
Vienna 57
Tongling 55
Munich 53
Moscow 49
Boardman 47
Houston 45
Hong Kong 43
North Bergen 43
Atlanta 42
São Paulo 41
Bosa 40
Rome 39
Warsaw 38
Phoenix 37
Brooklyn 35
Orem 34
Shenyang 34
Teramo 33
Milan 32
Woodbridge 32
Hebei 31
Helsinki 31
Denver 30
Jiaxing 30
Columbus 29
Kocaeli 28
Montreal 28
Redondo Beach 28
Tianjin 28
Toronto 27
Chennai 26
Kunming 26
Tokyo 26
Jinan 25
Vilnius 25
Bologna 23
Brno 23
Changsha 23
Hefei 23
Brussels 22
Ottawa 22
London 21
Da Nang 20
Stockholm 20
Fairfield 19
Frankfurt am Main 19
Hangzhou 18
Ningbo 18
Chicago 17
Poplar 16
Mount Pleasant 15
Turku 15
Nuremberg 14
Haiphong 13
Johannesburg 13
Rio de Janeiro 13
Falls Church 12
Guangzhou 12
Mexico City 12
Norwalk 12
San Francisco 12
San José 12
Ankara 11
Dong Ket 11
Kingston 11
League City 11
Naples 11
Seattle 11
Amsterdam 10
Bari 10
Totale 9.157
Nome #
Valutazione biologica e computazionale di inibitori della Ossido Nitrico Sintasi 263
Anticancer Activity of Stilbene-Based Derivatives 206
Synthesis and antibacterial evaluation of oxazolidin-2-ones structurally related to linezolid 205
Synthesis of 2-aryloxypropanoic acids analogues of clofibric acid and assignment of the absolute configuration by 1H NMR spectroscopy and DFT calculations 204
Discovery of N-{3-[(ethanimidoylamino)methyl]benzyl}-L-prolinamide dihydrochloride: A new potent and selective inhibitor of the inducible nitric oxide synthase as a promising agent for the therapy of malignant glioma 197
Amidine N-sostituite come potenziali inibitori delle Ossido Nitrico Sintasi 190
Titanium-Promoted Acylation of Sulfonamides to N-Acylsulfonamide PPAR Antagonists 188
Novel Phenyldiazenyl Fibrate Analogues as PPAR α/γ/δ Pan-Agonists for the Amelioration of Metabolic Syndrome 188
Hemopressin peptides as modulators of the endocannabinoid system and their potential applications as therapeutic tools 185
Recent developments of amidine-like compounds as selective NOS inhibitors 184
Synthesis, biological activity, and docking studies of novel acetamidines as selective modulators of nitric oxide synthase 183
Valutazione biologica dei derivati dell'acido clofibrico come potenziali ligandi PPARs 183
Synthesis and structure-activity relationships of fibrate-based analogues inside PPARs 183
Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation 179
Asymmetric Synthesis of Arylpropionic Acids and Aryloxy Acids by Using Lactamides as Chiral Auxiliaries 178
Synthesis and Biological Evaluation of 2-Heteroarylthioalkanoic Acid Analogues of Clofibric Acid as Peroxisome Proliferator-Activated Receptor alfa Agonists 176
Cytotoxic effect of a family of Peroxisome Proliferator-Activated Receptor antagonists in colorectal and pancreatic cancer cell lines 175
Discovery of new FXR agonists based on 6-ECDCA binding properties by virtual screening and molecular docking 171
Synthesis of benzothiazolyl-thioalkanoic acids and pharmacological evaluation on PPARa 170
Benzothiazole-based N-(phenylsulfonyl)amides as a novel familyof PPARa antagonists 170
Determinazione della configurazione assoluta di acidi carbossilici a-sostituiti di interesse farmaceutico attraverso spettroscopia NMR 169
Synthesis and biological evaluation of potential Nitric Oxide Synthase inhibitors 169
The Selective Acetamidine-Based iNOS Inhibitor CM544 Reduces Glioma Cell Proliferation by Enhancing PARP-1 Cleavage In Vitro 167
Druggability profile of stilbene-derived PPAR agonists: Determination of physicochemical properties and PAMPA study 166
Candida rugosa lipase-catalysed kinetic resolution of 2-substituted-aryloxyacetic esters with dimethylsulfoxide and isopropanol as additives 165
Enantiomeric separation of Gemfibrozil chiral analogues by capillary electrophoresis with heptakis(2,3,6-tri-O-methyl)-beta-cyclodextrin as chiral selector 162
PPARα agonists based on stilbene and its bioisosteres: Biological evaluation and docking studies 161
Synthesis and biological evaluation of gemfibrozil chiral analogs as potential PPARa agonists 157
Synthesis and biological characterization of 3-(imidazol-1-ylmethyl)piperidine sulfonamides as aromatase inhibitors 155
Syntesis and pharmacological evaluation of fibrates analogues as cardiovascular agents 154
Fibrate-derived N-(methylsulfonyl)amides with antagonistic properties on PPARa 153
Synthesis and cytotoxic effects on pancreatic cancer cells of resveratrol analogs 153
Advancements in the Research of New Modulators of Nitric Oxide Synthases Activity 152
Indazole, Pyrazole, and Oxazole Derivatives Targeting Nitric Oxide Synthases and Carbonic Anhydrases 152
Synthesis and antiplatelet activity of clofibric acid analogues 150
Sintesi e valutazione biologica di analoghi eterociclici del gemfibrozil a potenziale attività cardiovascolare 150
Sulfonimide and Amide Derivatives as Novel PPARα Antagonists: Synthesis, Antiproliferative Activity, and Docking Studies 150
Amidine-Based Bioactive Compounds for the Regulation of Arginine Metabolism 149
Convergent Solution Phase and Solid Phase Synthesis for the Preparation of beta- Lactam antibiotic libraries. 148
Synthesis, biological evaluation and docking studies of N-substituted acetamidines as selective inhibitors of inducible nitric oxide synthase 148
Amidine-Based Compounds Affecting L-Arginine Metabolism 148
Selective Acetamidine-Based Nitric Oxide Synthase Inhibitors: Synthesis, Docking, and Biological Studies 147
Synthetic Strategies to Serine-Proline Chimeras: An Overview 147
Benzothiazole Derivatives Endowed with Antiproliferative Activity in Paraganglioma and Pancreatic Cancer Cells: Structure-Activity Relationship Studies and Target Prediction Analysis 146
Selective inhibition of inducible Nitric Oxide Synthase by derivatives of acetamidine 146
Fibrate-based N-acylsulphonamides targeting carbonic anhydrases: synthesis, biochemical evaluation, and docking studies 145
Synthesis, characterization and evaluation of gemfibrozil-stilbene hybrid as antioxidant agent 143
Structural development studies of PPARs ligands based on tyrosine scaffold 142
Novel aminobenzyl-acetamidine derivative modulate the differential regulation of NOSs in LPS induced inflammatory response: Role of PI3K/Akt pathway 142
Synthesis of naphthyl-, quinolin- and anthracenyl analogues of clofibric acid as PPARα agonists 142
The excitation-contraction coupling on C2C12 skeletal muscle myotubes was modulated by NO-donor ester of gemfibrozil 141
N-Substituted acetamidines and 2-methylimidazole derivatives as selective inhibitors of neuronal nitric oxide synthase 140
Discovery of gemfibrozil analogues that activate PPARa and enhance the expression of gene CPT1A involved in fatty acids catabolism 140
Synthesis and biological evaluation of new acetamidines as selective inhibitors of Nitric Oxide Synthases 139
Design, synthesis and biological activity of selective hCAs inhibitors based on 2-(benzylsulfinyl)benzoic acid scaffold 138
Multitarget PPARγ agonists as innovative modulators of the metabolic syndrome 137
Analoghi eterociclici dell’acido clofibrico: sintesi, attività antiaggregante piastrinica e separazione in elettroforesi capillare 136
Starting a new series of acetamidines as Nitric Oxide Sinthase inhibitors 135
Dynamic kinetic resolution of α-bromoesters containing lactamides as chiral auxiliaries 134
CAPE derivatives: Multifaceted agents for chronic wound healing 132
Synthesis and biological evaluation of novel acetamidines as nitric oxide inhibitors 132
Synthesis of potential dual binding site acetylcholinesterase inhibitors through an efficient solid phase approach based on the Mitsunobu reaction 132
Dual-PPAR agonists based on stilbene scaffold: synthesis and biological evaluation 131
Targeting neuronal nitric oxide synthase as a valuable strategy for the therapy of neurological disorders 131
Selective Inhibition of iNOS by Benzyl- and Dibenzyl Derivatives of N-(3-Aminobenzyl)acetamidine. 131
Azobenzenesulfonamide Carbonic Anhydrase Inhibitors as New Weapons to Fight Helicobacter pylori: Synthesis, Bioactivity Evaluation, In Vivo Toxicity, and Computational Studies 129
Platelet aggregation: synthesis and pharmacological evaluation of clofibric acid analogues 129
Azobenzene as Multi-Targeted Scaffold in Medicinal Chemistry 128
Sintesi di esteri del gemfibrozil donatori di ossido nitrico 128
Effect of stilbene and chalcone scaffolds incorporation in clofibric acid on PPARα agonistic activity 128
null 128
Design, synthesis and biological evaluation of aromatase inhibitors based on sulfonates and sulfonamides of resveratrol 128
New amidine-benzenesulfonamides as iNOS inhibitors for the therapy of the triple negative breast cancer 126
Synthesis and cytotoxicity evaluation of novel amide and sulfonimide PPARa antagonists 126
A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential 126
Selective inhibition of iNOS by benzyl- and dibenzyl derivatives of N-(3-aminobenzyl)acetamidine on cellular line H2C9 124
Synthetic methodologies for the preparation of arginine-proline derivatives 124
Synthesis, biological evaluation, and docking study of indole aryl sulfonamides as aromatase inhibitors 124
Methods to Evaluate the Activity of Nitric Oxide Synthase 121
Design, synthesis and biological evaluation of imidazole and triazole-based carbamates as novel aromatase inhibitors 121
Synthesis of novel benzothiazole amides: Evaluation of PPAR activity and anti-proliferative effects in paraganglioma, pancreatic and colorectal cancer cell lines 121
A novel life for antitumor combretastatins: Recent developments of hybrids, prodrugs, combination therapies, and antibody-drug conjugates 120
Novel Phenyldiazenyl Fibrate Analogues as PPAR Agonists: Design, Synthesis and Pharmacological Evaluation 120
Synthesis, structure-activity relationships and molecular docking studies of phenyldiazenyl sulfonamides as aromatase inhibitors 120
In vitro protective effects of resveratrol and stilbene alkanoic derivatives on induced oxidative stress on c2c12 and mcf7 cells 119
Targeting iNOS As a Valuable Strategy for the Therapy of Glioma 117
N-substituted acetamidines as nitric oxide synthase inhibitors 115
Choline Chloride-Based DES as Solvents/Catalysts/Chemical Donors in Pharmaceutical Synthesis 115
Sintesi di derivati eterociclici dell’acido clofibrico a potenziale attività antiaggregante piastrinica 114
Fibrate-Based Analogues as PPARs Agonists: Synthesis and Structure–Activity Relationships 114
“Insight into diastereospecific solvolysis of peptidyl-b-lactams: combined kinetic and conformational studies” 114
Design, synthesis and biological evaluation of novel acetamidines as selective inducible nitric oxide synthase inhibitors 113
Capillary electrophoretic enantioseparation of gemfibrozil analogues by use of TM-b-cyclodextrin as chiral selector 113
Acetamidine-Based iNOS Inhibitors as Molecular Tools to Counteract Inflammation in BV2 Microglial Cells 112
QSAR, QSPR and QSRR in terms of 3-D-MoRSE descriptors for in silico screening of clofibric acid analogues 110
Reversed-phase high-performance liquid chromatography method with fluorescence detection to screen nitric oxide synthases inhibitors. 110
Activators of Nrf2 to Counteract Neurodegenerative Diseases 108
In vitro evaluation of a new selective iNOS inhibitor on normal rat astrocytes and C6 rat glioma cells 107
Screening of NOS activity and selectivity of newly synthesized acetamidines using RP-HPLC 103
Insights into diastereospecific solvolysis of peptidyl-beta-lactams: combined kinetic and conformational studies 98
Totale 14.538
Categoria #
all - tutte 60.453
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.453


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022508 0 0 0 0 70 18 24 49 97 30 71 149
2022/20231.712 124 243 127 169 162 345 88 129 213 21 56 35
2023/2024791 56 26 73 21 48 250 192 10 3 30 8 74
2024/20252.063 92 394 348 46 37 95 116 124 176 94 269 272
2025/20264.617 354 150 411 600 538 263 808 306 477 377 222 111
2026/20271.350 108 219 249 579 195 0 0 0 0 0 0 0
Totale 15.961